Clinical Trials
7 trialsNCT05103605 2025-12-01
POSITHES
AstraZeneca
Active not recruiting
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04179890 2023-05-25
UpSwinG
Boehringer Ingelheim
Completed
NCT05513664 2022-08-24
Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc.
Unknown
NCT03219970 2021-09-14
Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.
AstraZeneca
Completed
NCT03370770 2020-12-24
Afatinib Osimertinib Sequencing NIS
Boehringer Ingelheim
Completed
NCT03133234 2018-11-20
Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC
AstraZeneca
Completed